HFG
MRNA icon

Heron Financial Group’s Moderna MRNA Stock Holding History

Heron Financial Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,528
Closed -$235K – 144
2023
Q1 		$235K Buy
1,528
+220
+17% +$36.3K 0.13% 125
2022
Q4 		$227K Buy
+1,308
New +$214K 0.15% 114
2022
Q3 		– Sell
-1,490
Closed -$213K – 137
2022
Q2 		$213K Buy
1,490
+98
+7% +$14K 0.13% 126
2022
Q1 		$240K Buy
+1,392
New +$234K 0.12% 130
2021
Q4 		– Sell
-767
Closed -$295K – 152
2021
Q3 		$295K Buy
+767
New +$283K 0.16% 107

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Heron Financial Group's MRNA Position: Q2 2023 in Review

Heron Financial Group sold out of Moderna (MRNA) in Q2 2023, closing a stake of 1,528 shares — an estimated $235K sold.

Heron Financial Group first reported a position in MRNA in Q3 2021 and held it in 5 quarters. The position peaked at $295K in Q3 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

  • Heron Financial Group reported no remaining Moderna position as of Q2 2023 after selling out during the quarter.
  • Heron Financial Group sold 1,528 Moderna shares in Q2 2023, an estimated $235K.
  • Heron Financial Group first reported a position in Moderna in Q3 2021 and held it in 5 quarters.
  • Heron Financial Group's Moderna position peaked at $295K in Q3 2021.
  • 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Heron Financial Group's 13F filing for Q2 2023, filed 10 Aug 2023.